Safety and efficacy of reduced-dose pentamidine as second-line treatment for HIV-related pneumocystis pneumonia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Safety and efficacy of reduced-dose pentamidine as second-line treatment for HIV-related pneumocystis pneumonia

Published:2020-11 Issue:11 Volume:26 Page:1192-1197
ISSN:1341-321X
Container-title:Journal of Infection and Chemotherapy
language:en
Short-container-title:Journal of Infection and Chemotherapy

Author:

Mutoh Yoshikazu,Teruya Katsuji,Aoki Takahiro,Kikuchi Yoshimi,Gatanaga Hiroyuki,Oka Shinichi

Funder

Japan Agency for Medical Research and Development

Publisher

Elsevier BV

Subject

Infectious Diseases,Pharmacology (medical),Microbiology (medical)

Reference35 articles.

1. The safety of IV pentamidine administered in an ambulatory setting;Yeung;Chest,1996

2. Incidence of cardiac arrhythmias during intravenous pentamidine therapy in HIV-infected patients;Eisenhauer;Chest,1994

3. New insights into transmission, diagnosis, and drug treatment of Pneumocystis carinii pneumonia;Kovacs;J Am Med Assoc,2001

4. Intravenous or inhaled pentamidine for treating Pneumocystis carinii pneumonia in AIDS. A randomized trial;Conte;Ann Intern Med,1990

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Repurposing antiparasitic drugs for the treatment of other diseases;Advances in Antiparasitic Therapies and Drug Delivery;2024

2. Pentamidine;Reactions Weekly;2020-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP